Effects of Tamoxifen and interferon-β or the combination on tumor- induced angiogenesis

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 456-461

  Lindner, Daniel J ^a,b   Borden, Ernest C ^a,c,d  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ESTRADIOL; TAMOXIFEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL DIVISION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON-BETA; MICE; MICE, INBRED STRAINS; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; OVARIECTOMY; TAMOXIFEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030972847     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<456::AID-IJC25>3.0.CO;2-C     Document Type: Article

References (19)

1. ARANY, I., RADY, P. and TYRING, S.K., Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF β 1/IFN β cytokine pathway. Antiviral Res., 23, 131-141 (1994).
2. ARTEAGA, C.L., TANDON, A.K., VON HOFF, D.D. and OSBORNE, C.K., Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor negative human breast cells. Cancer Res.. 48, 3898-3904 (1988).
3. CROXTALL, J.D., EMMAS, C., WHITE, J.O., CHOUDHARY, Q. and FLOWER, R.J., Tamoxiten inhibits growth of oestrogen receptor-negative A549 cells. Biocheni. Pharmacol. 47, 197-202 (1994).
4. EZEKOWITZ, R.A.B., MILLIKEN, J.B. and FOLKMAN, J., Interferon α-2a therapy for life-threatening hemangiomas of infancy. New Eng. J. Med., 326, 1456-1463 (1992).
5. GAGLIARDI, A. and COLLINS, D.C., Inhibition of anaiogenesis by antiestrogens. Cancer Res., 53, 533-535 (1993).
6. GIBSON, D.F.C., JOHNSON, D.A., GOLDSTEIN, D., LANGAN-FAHEY, S.M., BORDEN, E.G. and JORDAN, V.C., Human recombinant IFN-beta ser and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse. Breast Cancer Res. Treat., 25, 141-150 (1993).
7. GOTTARDIS, M.M., WAGNER, R.J., BORDEN, E.C. and JORDAN, V.C., Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro. Cancer Res., 49, 4765-4769 (1989).
8. GRENMAN, S.E., ROBERTS, J.A., ENGLAND, B.G., GRONROOS, M. and CAREY, T.E., In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate. Gynecol. Oncol., 30, 239-250 (1988).
9. HARAN, E.F., MARETZEK, A.F., GOLDBERG, I., HOROWITZ, A. and DECANI, H., Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res., 54, 5511-5514 (1994).
10. KERR, D.J., PRAGNELL, I.B., SFROUL, A., COWAN, S., MURRAY, T., GEORGE, D. and LEAKE, R., The cytostatic effects of alpha-interferon may be mediated by transforming growth factor-beta. J. Mol. Endocrinol., 2, 131-136 (1989).
11. LINDNER, D.J. and BORDEN, E.C., Synergistic antitumor effects of acombination of interferon and tamoxiten on estrogen receptor-positive and -negative human tumor cell lines in vivo and in vitro. (1997) in press.
12. LINDNER, D.J., KOLLA, V., KALVAKOLANU, D.V. and BORDEN, E.G., Tamoxifen enhances interferon-reaulated sene expression in breast cancer cells. Mo.l Cell. Biochem., 167, 169-177 (1997).
13. MAHESHWARI, R.K., SRIKANTAN, V., BHARTIYA, D., KLEINMAN, H.K. and GRANT, D.S., Differential effects of interferon aamma and alpha on in vitro model of angiogenesis. J. Cell. Physiol., 146, 164-169 (1991).
14. MALET, C., COMPEL, A., SPRITZER, R. BRICOLT, N., YANEVA, H., Mowszowicz, I., KUTTENN, F. and MAUVAIS-JARVIS, P., Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Cancer Res., 48, 7193-7199 (1988).
15. SGADARI, C., ANGIOLILLO, A.L. and TOSATO, G., Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood, 87, 3877-3882 (1996).
16. SIDKY, Y.A. and AUERBACH, R., Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J. Exp. Med., 141, 1084-1100 (1975).
17. SIDKY, Y.A. and BORDEN, E.G., Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res., 47, 5155-5161 (1987).
18. SINGH, R.K., GUTMAN, M., BUCANA, C.D., SANCHEZ, R., LLANSA, N. and FIDLER, I.J., Interferons alpha and beta down-regulate the expression of basic tibroblast srowth factor in human carcinomas. Proc. Nat. Acad. Sci. (Wash.), 92, 4562-4566 (1995).
19. TANAKA, N.G., SAKAMOTO, N., KORENAGA, H., INOUE, K., OGAWA, H. and OSADA, Y. The combination of a bacterial polysaccharide and tamoxifen inhibits aneiogenesis and tumour growth. Int. J. Rad. Biol.. 60, 79-83 (1991).